Inflammatory cytokine networks and immune system

The inflammatory cytokine network and immune system represent a complex, interconnected web of signaling proteins and cellular interactions that coordinate the body's response to injury and infection (Source: NIH). Cytokines, including interleukins, interferons, and tumor necrosis factors, act as chemical messengers that bind to specific cell-surface receptors to trigger intracellular signaling cascades, such as the JAK-STAT pathway (Source: Nature Reviews Immunology). While essential for host defense, dysregulation of these networks leads to chronic inflammation and autoimmune disorders like rheumatoid arthritis and psoriasis (Source: PubMed). Therapeutic strategies do not target the entire system as a single entity but rather focus on specific nodes, such as individual cytokines or receptors, to modulate the immune response (Source: PMC). Modern drug discovery often utilizes systems biology to predict how perturbations in one part of the network affect the overall immune balance (Source: Frontiers in Immunology). Consequently, while this system is the context for many therapies, it is considered too broad to be a single therapeutic target and instead serves as a framework for understanding multi-target interactions.

Other names

Cytokine networkImmune system signalingInflammatory cascadeCytokine signaling pathwaysImmune system mediators

Pharmacological agents modulate these networks by neutralizing specific pro-inflammatory cytokines, blocking their cognate receptors, or inhibiting downstream intracellular signaling components such as Janus kinases (JAKs) to prevent the transcription of inflammatory genes (Source: StatPearls, Nature Reviews Immunology).